In addition, Eisai must conduct a post-authorization safety study, including setting up a patient registry for the European Union. Now each European country must set its own rules for access and ...

Talk about a closely watched study. Conference after conference, Roche scientists running the ongoing Brain Shuttle AD trial of trontinemab are dispensing morsels of news from sequential interim ...

Do you know a conference you think we should list? Let us know by sending us an email with the details to [email protected].

Member reports the following financial or other potential conflicts of interest: E. Solje has served on the advisory board of Novartis, EISAI, Lilly and Roche, served as a consult for Novo Nordisk, ...

Jean-François Démonet trained as an MD and Neurologist (1987) at Toulouse University; training in Neuropsychology at Montreal University and in brain imaging in R. Frackowiak’s lab in London UK with a ...

Average Award $300,000-$350,000 based on stage and scope of research. Slightly higher budgets can be considered. One year with potential for follow-on funding.